From: Next-generation sequencing profiling of mitochondrial genomes in gout
Gene | Position | Mutation | Locationa | Nucleotide numberb | HF (%) | Absent in control | Fre (%)c | CI (%) | Alterationd | Published disease association |
---|---|---|---|---|---|---|---|---|---|---|
MT-TQ e | 4386 | T➔C | D-loop | 15 | 99.8599.61 | + | 1.89 | 64.71 | ||
MT-TW | 5528 | T➔C | D-loop | 18 | 70.53 | + | 0.00 | 11.76 | ||
MT-TW | 5557 | T➔C | V region | 48 | 80.18 | + | 0.15 | 47.06 | ||
MT-TW | 5563 | G➔A | T-loop | 55 | 51.92 | + | 0.30 | 11.76 | ||
MT-TA | 5601 | C➔T | T-loop | 59 | 77.10 | + | 1.37 | 47.06 | ||
MT-TA | 5628 | T➔C | AC stem | 31 | 99.61 | + | 0.15 | 94.12 | + | Hearing loss, hypertension, ophthalmoplegia and dysphagia [37,38,39] |
MT-TC | 5783 | G➔A | T-stem | 50 | 99.58 | + | 0.04 | 94.12 | + | Encephalomyopathy, deafness, myopathy, cardiomyopathy, and renal failure [40, 41] |
MT-TC | 5814 | T→C | D-stem | 13 | 59.30 | + | 0.37 | 88.24 | + | Encephalomyopathy [42] |
MT-TH | 12,172 | A→G | AC loop | 38 | 99.67 | + | 1.15 | 88.24 | + | |
MT-TH | 12,178 | C→T | V region | 44 | 71.81 | + | 0.00 | 64.71 | + | |
MT-TS2 | 12,234 | A→G | AC stem | 42 | 55.90 | + | 0.30 | 58.82 | ||
MT-TS2 | 12,239 | C→T | V region | 48 | 66.70 | + | 0.96 | 64.71 | ||
MT-TS2 | 12,248 | A→G | T-loop | 57 | 99.59 | + | 0.11 | 100.00 | ||
MT-TT | 15,894 | G→A | ACC stem | 7 | 99.52 | + | 0.04 | 88.24 | + | |
MT-TT | 15,940 | T→C | T-loop | 59 | 65.31 | + | 0.11 | 41.18 |